Mowat–Wilson Syndrome

Mowat–Wilson syndrome (MWS) is a rare genetic disorder characterized by a constellation of clinical features resulting from impaired development. It is recognized for its significant intellectual disability, characteristic facial features, and a high prevalence of congenital anomalies, particularly Hirschsprung disease and genitourinary abnormalities. The syndrome's variable expressivity means that individuals can present with a wide range of symptoms and severity.

The syndrome was first delineated in 1998 by Australian geneticists Dr. Richard Mowat and Dr. David Wilson.

They described a series of unrelated patients exhibiting a similar pattern of developmental delay, intellectual disability, and distinctive facial features, including a prominent forehead, a broad nasal bridge, a small chin, and a short philtrum. Subsequent genetic studies identified mutations in the ZEB2 gene as the underlying cause.

Mowat–Wilson syndrome holds significance in understanding developmental disorders, particularly neurocristopathies – conditions arising from defects in neural crest cell development. The ZEB2 gene encodes a transcription factor crucial for epithelial-mesenchymal transition, a process vital for neural crest cell migration and differentiation. Disruptions in ZEB2 function lead to widespread developmental abnormalities affecting the nervous system, heart, gastrointestinal tract, and other organs.

MWS is caused by heterozygous loss-of-function mutations in the ZEB2 gene, located on chromosome 2q22.3. ZEB2 is a key regulator of the epithelial-mesenchymal transition (EMT), a fundamental process in embryonic development. Mutations in ZEB2 disrupt the normal migration, differentiation, and survival of neural crest cells, which contribute to a wide range of tissues and organs, explaining the pleiotropic effects observed in MWS.

The inheritance pattern is typically autosomal dominant, though de novo mutations are common.

The phenotypic spectrum of MWS is broad. Key features include moderate to severe intellectual disability, developmental delay, epilepsy, and characteristic facial dysmorphology. Gastrointestinal issues, most notably Hirschsprung disease, occur in a significant proportion of patients.

Congenital heart defects, genitourinary anomalies, and skeletal abnormalities are also frequently observed. Management is supportive and multidisciplinary, focusing on addressing specific medical concerns, optimizing developmental potential, and providing comprehensive care.